Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Abstract Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from Cannabis sativa. CBD is a terpenophenol and…
Abstract Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from Cannabis sativa. CBD is a terpenophenol and…
Abstract Arrestin translocation and signaling have come to the fore of the G protein-coupled receptor molecular pharmacology field. Some receptor–arrestin…
Abstract Background: Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world…
Abstract Healthcare is undergoing a transformation, and it is imperative to leverage new technologies to generate new data and support…
Abstract The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last decade. The immense data load…
Abstract With the increase of life expectancy, neurodegenerative disorders are becoming not only a health but also a social burden…
Abstract Cannabinoids (CBs) from Cannabis sativa provide relief for tumor-associated symptoms (including nausea, anorexia, and neuropathic pain) in the palliative…
Abstract The Achilles heel of thermoplastic natural fibre composites is their limited durability. The environmental degradation of the mechanical properties…
Abstract The inflorescence is the main product of medical cannabis. Hundreds of specialized metabolites with potential bioactivity are produced and…
Abstract Background: A substantial increase in substance treatment episodes for methamphetamine problems suggests characteristics of the treatment population could have…